Zimmer Biomet Holdings, Inc.
ZBH
$82.72
-$0.65-0.78%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.41B | 8.23B | 8.01B | 7.83B | 7.70B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.41B | 8.23B | 8.01B | 7.83B | 7.70B |
| Cost of Revenue | 2.51B | 2.50B | 2.28B | 2.25B | 2.22B |
| Gross Profit | 5.90B | 5.74B | 5.74B | 5.58B | 5.48B |
| SG&A Expenses | 3.30B | 3.21B | 3.08B | 2.97B | 2.90B |
| Depreciation & Amortization | 676.90M | 665.80M | 645.70M | 617.40M | 600.80M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.94B | 6.83B | 6.45B | 6.29B | 6.16B |
| Operating Income | 1.47B | 1.40B | 1.57B | 1.55B | 1.54B |
| Income Before Tax | 903.00M | 830.80M | 1.02B | 973.20M | 1.05B |
| Income Tax Expenses | 142.30M | 125.80M | 214.60M | 147.70M | 135.60M |
| Earnings from Continuing Operations | 760.70 | 705.00 | 807.40 | 825.50 | 915.20 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 400.00K | 0.00 | -2.20M | -2.10M | -1.80M |
| Net Income | 761.10M | 705.00M | 805.20M | 823.40M | 913.40M |
| EBIT | 1.47B | 1.40B | 1.57B | 1.55B | 1.54B |
| EBITDA | 2.58B | 2.49B | 2.64B | 2.59B | 2.55B |
| EPS Basic | 3.87 | 3.56 | 4.06 | 4.12 | 4.53 |
| Normalized Basic EPS | 3.77 | 3.55 | 4.00 | 3.99 | 4.03 |
| EPS Diluted | 3.86 | 3.55 | 4.03 | 4.10 | 4.51 |
| Normalized Diluted EPS | 3.76 | 3.54 | 3.99 | 3.97 | 4.01 |
| Average Basic Shares Outstanding | 788.20M | 792.10M | 794.00M | 798.20M | 806.00M |
| Average Diluted Shares Outstanding | 791.00M | 794.90M | 796.70M | 800.90M | 809.00M |
| Dividend Per Share | 0.96 | 0.96 | 0.96 | 0.96 | 0.96 |
| Payout Ratio | 24.89% | 26.99% | 23.70% | 23.38% | 21.28% |